Search for: ""Merck KGaA v. Integra Lifesciences I, Ltd." OR "545 U.S. 193"" Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Federal Circuit Debates Scope of 271(e)(1) Safe Harbor and the Meaning of “Solely”
27 Mar 2024, 4:46 pm by Dennis Crouch
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005). [read post]
Patently-O - https://patentlyo.com
Most Cited Supreme Court Patent Decisions (2005-2015)
11 Mar 2015, 9:40 am by Dennis Crouch
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005) (research exception to infringement) F.T.C. v. [read post]
Patently-O - http://patentlyo.com/patent
CAFC interprets the the Hatch-Waxman safe harbor provision, 35 U.S.C. § 271(e)(1)
7 Aug 2012, 11:45 pm by Lawrence B. Ebert
Integra Lifesciences I, Ltd., 545 U.S. 193, 202 (2005) (citing Eli Lilly, 496 U.S. at 665-69). [read post]
IPBiz - http://ipbiz.blogspot.com/
271(e) Safe Harbor Applies to Unfair Import Investigations Until Infringing Acts are Reasonably Likely to Occur
20 Mar 2008, 8:18 am
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005) the Court explained that Congress intended that the immunity of regulatory activity not be inhibited, stating that "'271(e)(1)'s exemption from infringement extends to all uses of patented inventions that are reasonably related to the development and submission of any information under the FDCA. [read post]
I/P Updates - http://ip-updates.blogspot.com/
The patent legacy of Supreme Court Justice Antonin Scalia
26 Feb 2016, 1:21 pm by Gene Quinn
Merck KGAA v. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu
Status of Research Tool Patents Still in Limbo
2 Aug 2007, 1:27 pm
Integra Lifesciences I, Ltd., 545 U.S. 193, 202 (2005). [read post]
Patent Baristas - http://www.patentbaristas.com
Federal Circuit Rules That Hatch-Waxman “Safe Harbor” is Quite Broad in Dispute Over Enoxaparin Method Patent
7 Aug 2012, 7:43 pm by FDABlog HPM
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005), and on the Hatch-Waxman legislative history of 35 U.S.C. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/